相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis
Di Yang et al.
CELL DEATH & DISEASE (2022)
The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell-monocyte crosstalk and protects against atherosclerosis via the NF-κB pathway
Floriana Maria Farina et al.
EUROPEAN HEART JOURNAL (2022)
The language of chromatin modification in human cancers
Shuai Zhao et al.
NATURE REVIEWS CANCER (2021)
Epigenetic priming by Dot1l in lymphatic endothelial progenitors ensures normal lymphatic development and function
Hyunjin Yoo et al.
CELL DEATH & DISEASE (2020)
Non-coding RNAs in vascular disease - from basic science to clinical applications: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
Jan Fiedler et al.
CARDIOVASCULAR RESEARCH (2018)
Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities
Gabriele G. Schiattarella et al.
VASCULAR PHARMACOLOGY (2018)
MicroRNA-Based Therapy of GATA 2-Deficient Vascular Disease
Dorothee Hartmann et al.
CIRCULATION (2016)
DOT1L-mediated H3K79me2 modification critically regulates gene expression during cardiomyocyte differentiation
P. Cattaneo et al.
CELL DEATH AND DIFFERENTIATION (2016)
Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization
Jan Fiedler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease
Douwe Pons et al.
EUROPEAN HEART JOURNAL (2009)
Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: implications for endothelial dysfunction and vascular biology
T Thum et al.
FASEB JOURNAL (2000)
分享论文
